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Abstract
DEEP HYPOTHERMIC CIRCULATORY ARREST EFFECTIVELY PRESERVES
NEUROCOGNITIVE FUNCTION.
Katherine H. Chau, Tamir Friedman, Maryann Tranquilli, John A. Elefteriades. Section
of Cardiothoracic Surgery, Yale University School of Medicine, New Haven, CT.
Few (conflicting) studies have quantitatively assessed neurocognitive effects of
deep hypothermic circulatory arrest (DHCA), and even fewer have looked at the longterm effects of DHCA. In this study, we aim to determine if DHCA negatively affects
neurocognitive function and if so, are the effects long-term. We assess neurocognitive
function quantitatively before and after DHCA and also in comparison with non-DHCA
patients. 62 aortic surgical patients underwent a battery of neuropsychometric tests, both
pre and post-operatively, evaluating multiple aspects of memory, processing speed,
executive function, and global cognition. 33 patients did not require DHCA, and 29
underwent DHCA as the sole means of cerebral protection. Of these, 19 patients who
tested positive for cognitive deficits, 8 of whom underwent DHCA and 11 who did not,
were followed long-term with an additional testing months to years post-operatively.
“Neurocognitive deficit” was defined as greater than 20% decline in two or more
cognitive areas. Pre and post-operative test scores, as well as incidence of
“neurocognitive deficit”, were compared within each group (post versus pre-operatively),
and between the non-DHCA and DHCA groups. There were no significant differences in
the post versus pre-operative scores in any cognitive area tested between DHCA and nonDHCA groups. There was also no difference between the two groups in incidence of
“neurocognitive deficit”: 13 non-DHCA, 11 DHCA (p = 1.00). In addition, there was no
correlation between time under DHCA and incidence of “neurocognitive deficit”. Within
both groups, there was a mild decline in memory in the areas of acquisition, retention,

	
  
and delayed recall. Within the DHCA group, recognition was also affected. Time under
DHCA up to 40 minutes was also found to be safe neurocognitively. Of the 24 patients
that who incurred a “neurocognitive deficit,” 19 participated in further follow-up, and of
these, 4 DHCA and 2 non-DHCA patients had persistent memory deficits (p = 0.32).
There was also no statistically significant difference in duration under DHCA between
those who did or did not recover from their deficits (p = 0.56). DHCA patients who did
have persistent memory deficits tended to have additional aspects of memory become
affected when tested at further follow-up. There was a statistically significant difference
in age, above or below 70 years old, between patients whose memory deficits persisted or
recovered (p < 0.001). While cardiac surgery had some effects on memory, overall
neurocognitive function was well preserved and did not differ between DHCA and nonDHCA patients. DHCA does not affect whether or not memory deficits incurred postoperatively persist, but in those patients who underwent DHCA whose memory deficits
did persist, those deficits tended to affect additional memory aspects that on previous
testing had not been affected. What does affect the temporal nature of memory deficits is
age, with patients over the age of 70 having a higher incidence of persistent long-term
memory deficits. This study provides strong evidence that straight DHCA effectively
preserves neurocognitive function.
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Introduction
Deep hypothermic circulatory arrest (DHCA) is a cerebral protection strategy that
has been an integral part of cardiac and aortic surgery for decades. It has been especially
important in advancing the feasibility of aortic arch operations, which entail unique
challenges. At our institution, we have found DHCA to be a safe and effective cerebral
protection method, and we employ DHCA in the vast majority of procedures involving
the aortic arch. However, while we favor the use of DHCA, that is not the case at other
institutions. A recent survey finds a variety of methods applied at expert institutions (1).
While the benefits of DHCA are well established, potential shortcomings have been
under debate—specifically if there are any negative effects on neurocognition and also
how long can a patient be safely under DHCA.
Thoracic Aortic Aneurysms
Approximately 10.4 per 100,000 people in the United States develop a thoracic
aortic aneurysm (TAA) each year (2). TAA is a silent, but lethal, disease, with 95% of
TAAs being asymptomatic before an acute event, such as dissection or rupture, occurs
(3). Aortic aneurysms (both abdominal and thoracic) represent the 15th leading cause of
death in individuals older than 55 years, and the 19th leading cause of death in individuals
of all ages—so that aortic aneurysms cause more deaths in the United States than human
immunodeficiency virus (HIV) (4).
Natural History and Progression. The aneurysmal thoracic aorta grows in a
generally indolent manner, increasing by about 1 mm each year. The average ascending
aneurysmal aorta expands by 0.10 cm annually, with the descending thoracic aneurysmal
aorta expanding at a slightly faster rate of 0.29 cm each year (5). Aneurysms with larger
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diameters, however, tend to expand more rapidly. The annual growth rate for a 4.0 cm
ascending TAA, for example, is 0.10 cm, while the annual growth rate for an 8.0 cm
ascending TAA is 0.19 cm (6). The relationship between annual growth rate and
aneurysm size is depicted in Figure 1. Dissected aortas also tend to grow more rapidly
than non-dissected aortas (6).

Figure 1. Absolute change in growth as a function of aortic size. Reprinted with
permission from Coady et al (6).

There are subgroups of TAA patients in whom aneurysm growth rate is faster, and
regular monitoring of aneurysm size is therefore even more crucial in avoiding
potentially fatal complications such as dissection and rupture. One such subgroup is
patients with familial TAAs. These patients’ TAAs grow at 0.21 cm/year (combined
ascending and descending TAA) compared with patients with sporadic TAAs (7). Loeys-
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Dietz syndrome patients grow at an especially rapid rate, with their TAAs sometimes
growing faster than 1.0 cm/year (7, 8).
Size of Aneurysm. In monitoring and managing TAAs, size has become the most
important parameter to follow. In our Yale studies, we showed that the risk of natural
complications, such as dissection or rupture or death, increases as TAAs get larger. In
fact, we have been able to produce calculations of the annual risk of complications based
solely on TAA size (Table 1) (9). Figure 2 graphically highlights the increase in risk of
complications that corresponds with increasing TAA size.
Table 1. Annual Risk of Complications Based on Thoracic Aortic Aneurysm Size

Annual Risk (%)

Aortic Size

Rupture

Dissection

Death

Rupture/Dissection/
Death

> 3.5 cm

0.0

2.2

5.9

7.2

> 4.0 cm

0.3

1.5

4.6

5.3

> 5.0 cm

1.7

2.5

4.8

6.5

> 6.0 cm

3.6

3.7

10.8

14.1
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Figure 2. Annual risk of complications based on thoracic aortic aneurysm size.

Aortic dissection and rupture have approximately the same annual incidence of
3.5 per 100,000 patients (10). Once dissection or rupture occurs, short-term and longterm outcomes diminish rapidly. Data from the International Registry of Acute Aortic
Dissection (IRAD) show that overall in-hospital mortality for acute thoracic aortic
dissection is 27.4%. In-hospital mortality for acute type A dissections is about 35% (26%
in patients undergoing surgical repair and 58% in patients managed non-surgically due to
age or comorbidities) (11). In-hospital mortality for acute type B dissections is somewhat
better at 12% (29%, 11%, and 10% for patients receiving surgical, endovascular, and
medical management, respectively) (12).
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Patients who have had dissected aortas have a severely compromised long-term

outlook, as nearly 40% will suffer a fatal aortic rupture or require additional intervention
(13). This is because, as mentioned above, previously dissected aortas expand at an
accelerated rate (6).
The prognosis for TAA rupture is even worse than dissection. Johannson et al
found that only 41% of patients with TAA rupture reach a hospital alive (14). For those
patients lucky enough to make it to a hospital alive, the peri-operative mortality for
surgical repair of the ruptured descending aorta is 28.6% and 23.4% for endovascular
repair (15).
Our graphs and nomograms allow physicians to form a reasonable estimate of a
specific patient’s risk of dissection, rupture, or death from the TAA for each future year
of life if the aorta is not resected; this permits an evidence based decision on management
of the TAA.
Indications for Surgery. Our Yale studies have shown that once the aortic
aneurysm has grown to a certain size, there is a dramatic increase in the risk of acute
complications (rupture and dissection). In ascending aortic aneurysms, that “hinge point”
is 6.0 cm, and in descending aortic aneurysms, the “hinge point” is 7.0 cm, as can be seen
in Figure 3 (5).
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Figure 3. Effect of aortic aneurysm size on cumulative, lifetime incidence of
complications for the (A) ascending and (B) descending aorta. Reproduced with
permission from Coady et al (5).

It is important to note, however, that by the time the ascending aortic aneurysm
reaches 6.0 cm, 31% of patients have already suffered a dissection or rupture of the
aneurysm. By the time the descending aortic aneurysm reaches its “hinge point” of 7.0
cm, 43% of patients have already suffered a dissection or rupture (9). A surgeon should
therefore not wait until the aorta grows to its “hinge point” for intervention. Intervention
should be made before the “hinge point” is reached. Elective surgical treatment of TAAs
(very safe) is also highly beneficial to the patient over emergency surgical intervention
(very dangerous). The 5-year survival rate after elective extirpation of a TAA is
approximately 85%, achieving a survival curve approaching that of the healthy, agematched population. The 5-year survival rate after emergency surgical intervention, on
the other hand, is only 37% (Figure 4) (16).
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Figure 4. Kaplan-Meier survival curves after elective surgery, medical management, and
emergency surgery for thoracic aortic aneurysms. Reproduced with permission from
Davies et al (16).

Surgical intervention before the “hinge point” aortic size is reached is therefore
highly desirable, if possible. Our evidence-based recommendations for surgical
intervention based on size are summarized in Table 2 (17, 18).
Table 2. Thoracic Aortic Aneurysm Size Criteria for Elective Surgical Intervention

Non-Marfan’s

Marfan’s or Familial

Bicuspid Aortic Valve

Ascending

5.5 cm

5.0 cm

5.0 cm

Descending

6.5 cm

6.0 cm

N/Aa
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A bicuspid aortic valve increases the risk of dissection and rupture of an ascending

thoracic aortic aneurysm, but not a descending aneurysm (18).

Regardless of the size, though, all symptomatic aneurysms should be resected; the main
symptom is pain consistent with the aneurysm location and unexplained by other causes.
Rarely compression of adjacent organs (especially trachea, esophagus, or left main stem
bronchus) may be the presenting symptom. Ascending aneurysm patients may experience
congestive symptoms due to aortic insufficiency caused by distraction of the aortic valve
leaflets as the aorta expands (19). Aneurysmal growth rate of ≥ 1 cm/year (rare with
proper measurement techniques (20)) or substantial growth with the aneurysm rapidly
approaching the size criteria listed in Table 2 are also valid indicators for which we
would recommend surgical intervention (19).
DHCA
History Behind DHCA as a Cerebral Protection Strategy. The concept of using
hypothermia for organ preservation was not applied to cardiac surgery until the mid-20th
century when a few innovative and courageous surgeons discovered the usefulness of
deep hypothermia in surgery. The DHCA era began in 1952, when what is probably the
world’s first successful open-heart surgery was performed by American cardiac surgeon
John Lewis, who used systemic hypothermia with no cardiopulmonary bypass in his
closure of a secundum-type atrial septal defect (21).
Across the Atlantic Ocean in England, another cardiac surgeon was also paving
the way for the use of hypothermia in cardiac surgery. In 1957, Charles Drew began

	
  

9	
  

experimenting with the use of hypothermia in dogs. He found that it was possible to cool
a dog down to 15°C, turn off cardiopulmonary bypass, keep the dog under circulatory
arrest for 30 minutes, and then rewarm it with a subsequently normal heart rhythm. Based
on these pioneering animal experiments, Dr. Drew applied the technique in humans.
Called at that time the “Drew technique,” hypothermia was applied by Dr. Drew in
operations on both infants and adults until his retirement in 1981 (22).
Going further East, a cardiac surgeon was exploring the use hypothermia in
cardiac surgery in the mid-20th century. Professor Eugene N. Meshalkin worked in
central Siberia, where snow and ice were more than abundant. In the 1960s. He began
using the snow and ice as topical hypothermic agents to cool patients down to 28 to 29°C.
Using this technique, he operated on ventricular septal defects, atrioventricular canals,
and other congenital pathologies. It has been reported that he even operated on tetralogy
of Fallot cases and replaced mitral and aortic valves with hypothermia without
cardiopulmonary bypass (23, 24).
While the 1950s saw the start of the use of hypothermia in cardiac surgery, it
would still be another decade until hypothermia found its way into aortic surgery. In
1963, Barnard and Schrire introduced the use of hypothermia in thoracic aortic surgery,
describing three cases involving the aortic arch where profound hypothermia was used
during surgery (25). In these pioneering efforts, two patients died on the table or postoperatively, but one was discharged from the hospital in good condition. In the mid1970s, Randall Griepp validated the use of hypothermia for cerebral protection,
publishing additional successful operations in which hypothermia was used for cerebral
protection against ischemic injury during aortic arch replacement surgery (26). Based on
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Griepp’s exceptional clinical and scientific studies, hypothermia for aortic surgery
became a widely used and accepted method for cerebral protection during aortic arch
operations. More recently, other cerebral protection strategies have also been developed
and promoted, namely antegrade cerebral perfusion (ACP) and retrograde cerebral
perfusion (RCP). Many centers have adopted these new techniques in lieu of
hypothermia. However, which method—deep hypothermia, ACP, or RCP—is actually
the most effective and safest has been, and still is, under hot debate.
Science Behind DHCA. The brain is particularly susceptible to ischemic injury
due to its high metabolic rate of oxygen and glucose consumption, which is several times
faster than other organs (27). Though the brain only accounts for approximately 2% of
total body weight, it accounts for 20% of the resting total body oxygen consumption and
receives 15-20% of the cardiac output (28). Unlike other tissues, the brain does not have
stored glucose reserves, so that any interruption of blood flow has an immediate impact
on neuronal function (27).
DHCA is able to protect the brain from ischemic injury in a number of ways, one
of which is by lowering the brain’s high metabolic rate. It is well established that
hypothermia significantly decreases global cerebral metabolic rate for glucose and
oxygen. It has been shown that for every 1°C drop in body temperature, cellular
metabolism decreases by an average of 5 to 7% (29, 30). Therefore, at 18°C, cellular
metabolic rate is only 12 to 25% of the metabolic rate at normal body temperature
(Figure 5) (31).
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Figure 5. Decrease in cerebral metabolic rate with decreasing body temperatures.
Reprinted with permission from Kirklin JW et al. (31).

Another useful rule of thumb is that metabolism of any cell, tissue, organ, or organism
decreases exponentially as temperature falls—by 50% for every 6o C drop in temperature
(32). Hypothermia decreases anaerobic metabolism, and decreases lactic acid generation.
These effects minimize neuronal damage and necrosis that would otherwise have been
caused by the acidosis created by the excess lactic acid production (29).
Hypothermia also significantly reduces temperature-dependent release and
extracellular levels of excitatory neurotransmitters such as glutamate, a N-methyl-Daspartate (NMDA) receptor agonist. NMDA receptor activation leads to the unfavorable
release of calcium ions, which then enter cells and accumulate. This leads to activation of
intracellular proteases and mitochondrial dysfunction, resulting ultimately in neuronal
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cell death. Hypothermia reduces NMDA receptor activation, thus significantly decreasing
calcium ion release and preventing irreversible neuronal injury (33).
Hypothermia provides cerebral protection also by reducing neuronal apoptosis,
decreasing the release of pro-apoptotic proteins such as caspases and bcl-2, and by
interfering in pro-apoptotic pathways such as the mitogen-activated protein kinase
pathway. Hypothermia also significantly reduces free radical release after neuronal
damage and decreases the production of inflammatory cytokines. Yet another way that
hypothermia protects the brain from ischemic injury is by reducing post-ischemic
cerebral edema by decreasing disruption of the blood-brain barrier and damage of
endothelial vasculature after ischemia (33).
Overall, the protection of tissues by hypothermia reflects a panoply of powerful
and wide-ranging beneficial effects. Simply put, there is no better protection against
ischemic injury than hypothermia.
Comparison with Antegrade and Retrograde Cerebral Perfusion. Since DHCA
was first used as a cerebral protection method in aortic arch surgery in the 1960s by Drs.
Barnard and Schrire (25), other strategies for cerebral protection have been developed,
including ACP and RCP. Besides DHCA, these are two of the most commonly used
cerebral protection techniques during interventions on the aortic arch. There is
considerable debate about which of these three strategies offers superior cerebral
protection (34-36). We present here a summary of currently published data from large
studies that either describe their experience with one technique or compare outcomes
with different techniques (specifically, stroke and mortality rates) (Table 3).
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Table 3. Review of pertinent literature on post-operative outcomes of straight deep
hypothermic circulatory arrest, antegrade cerebral perfusion, and retrograde cerebral
perfusion.
Patients

Mortality

Stroke

(n)

(%)

(%)

First author

Comments
Retrograde Cerebral Perfusion

Safi, 1993 (37)

11

0

9.1

Ueda, 1994 (38)

33

12.1

6.1

Deeb, 1995 (39)

35

8.6

2.9

Lytle, 1995 (40)

43

9.3

9.3

Ueda, 1999 (41)

249

10

4

Ogino, 2001 (42)

28

0

3.6

Bavaria, 2002 (43)

163

9.8

3.0

Appoo, 2006 (44)

79

7.6

3.8

Retrospective
Type A dissections

Confined to elective cases

Antegrade Cerebral Perfusion
Matsuda, 1989 (45)

34

9.0

2.9

Bachet, 1991 (46)

54

13.0

1.8

Ando, 1994 (47)

42

7.1

7.0

Type A dissections (acute and
chronic)

Kazui, 1994 (48)

80

16.3

1.3

Tabayashi, 1994 (49)

77

19.4

5.0

Kazui, 2000 (50)

220

12.7

3.3

Di Eusanio, 2002 (51)

403

9.4

3.7
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Patients

Mortality

Stroke

First author

Comments
(n)

(%)

(%)

Bachet, 2002 (52)

206

17

4.5

Rate of non-fatal strokes 6%

Kazui, 2007 (53)

472

9.3

3.2

Probably includes patients from
studies in 1994 (50), 2000 (38)

Khaladj, 2008 (54)

501

11.6

9.6

9.6% PND, 13.4% TND.
Multivariate analysis relates PND
to renal insufficiency

Ogino, 2008 (55)
Toyama, 2009 (56)
Krahenbuhl, 2010 (57)

531

4.0

2.9

26

3.8

7.7

280

4.0

7.5

Retrospective

Mortality and stroke rates in
patients with mean circulatory
arrest time >40 min 6.8% and
13.7% respectively

Leshnower, 2010 (58)

412

7.0

3.6

Minakawa, 2010 (59)

122

8.2

4.1

Zierer, 2011 (60)

245

8.0

6.0

Retrospective

Retrospective, ACP combined
with mild HCA

Numata, 2012 (61)

164

6.1

7.9

Retrospective

Deep Hypothermic Circulatory Arrest
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Patients

Mortality

Stroke

First author

Comments
(n)

Svensson, 1993 (62)

656

(%)
12.0

(%)
7.0

DHCA > 45 min correlated with
stroke
DHCA > 65 min correlated with
death

Gega, 2007 (author’s

394

group) (63)

2.2 for

3.1 for

DHCA > 40 min correlated with

asc/arch

asc/arch

(embolic) stroke

Comparison studies
Deep Hypothermic Circulatory Arrest and Antegrade Cerebral Perfusion
Alamanni, 1995 (64)

DHCA =

DHCA =

DHCA

19

26.3

= 15.7

ACP =

ACP = 18.7 ACP =

16
Immer, 2004 (65)

Compared straight DHCA to ACP

12.5

DHCA =

Overall

DHCA

No comparisons of DHCA vs ACP

322

mortality=

= 6.5

were statistically significant

ACP =

8.6

ACP =

41

1.0
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Patients

Mortality

Stroke

First author

Comments
(n)

Halkos, 2009 (66)

(%)

(%)

DHCA =

DHCA =

Overall

Retrospective; method of

66

22.7

= 4.3

randomization to groups is

ACP =

ACP = 8.8

unclear; 61% of DHCA group

205

patients had emergent operations
compared to 32% of the ACP
group; DHCA stroke rate for
elective cases was 0

Kruger, 2011 (67)

DHCA =

DHCA =

DHCA

Retrospective. Results from 44

355

19.4

= 14.9

different centers. All patients with

ACP =

ACP = 14.8 ACP =

1081

Type A dissections

13.3

Deep Hypothermic Circulatory Arrest and Retrograde Cerebral Perfusion
Safi, 1997 (68)

Wong, 1999 (69)

DHCA =

Overall

DHCA

Retrospective study with large size

41

mortality =

=9

discrepancy between groups;

RCP = 20 6

RCP = 3

DHCA =

Overall

Overall

Nonrandomized; RCP was not

34

mortality=1

= 6.9

protective against for mortality or

RCP = 96 7

stroke.
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Patients

Mortality

Stroke

First author

Comments
(n)

Moon, 2002 (70)

(%)

DHCA =

DHCA =

DHCA

Retrospective case control; no

36

8.0

= 11.0

statistically significant difference

RCA =

in mortality or stroke between

6.0

groups.

RCP = 36 RCP = 11.0

Dong, 2002 (71)

(%)

DHCA =

DHCA =

DHCA

Retrospective; large size

15

20.0

= 25

discrepancy between patient

RCP =

groups

RCP = 50 RCP = 2.0

2.0
Harrington, 2003 (72) DHCA =
18

DHCA =

Overall

Prospective randomized trial to

5.5

= 2.6

evaluate effect of procedure

RCP = 20 RCP = 5.0

neuropsychometric outcomes; no
difference found between groups

Safi, 2011 (73)

DHCA =

DHCA =

DHCA

Retrospective, a trend towards

191

13.1

= 4.2

reduced mortality and stroke in the

RCP =

RCP = 8.6

RCP =

RCP group found

1002

2.8

Antegrade Cerebral Perfusion and Retrograde Cerebral Perfusion
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Patients

Mortality

Stroke

First author

Comments
(n)

Okita, 2001 (74)

(%)

(%)

RCP = 30 RCP = 6.6

RCP =

No straight DHCA patients; only

ACP =

3.3

difference found was higher

ACP =

incidence of transient brain

6.6

dysfunction in RCP patients.

RCP =

All patients with type A acute

ACP = 6.6

30

Apostolakis, 2008

RCP = 25 RCP = 16.6

(75)

ACP =

ACP = 13.0 4.0

23

ACP =

dissections. No significant
difference in mortality or stroke.

4.3
Milewski, 2010 (76)

a

Estrera, 2010 (77)

RCP =

RCP = 2.8

RCP =

RCP and ACP conducted in two

682

ACP = 3.2

2.8

different institutions. Arch

ACP =

ACP =

reconstruction period no longer

94

3.2

that 45 minutes in all cases.

RCP = 34 RCP = 9

RCP = 2 A select group of patients

ACP =

ACP =

requiring extended hypothermic

13

circulatory arrest (>40 min)

ACP = 20

30
Usui, 2012 (78)

RCP =

RCP = 4.1

RCP =

Retrospective. No significant

583

ACP = 5.3

3.1

difference between mortality or

ACP =

ACP =

stroke rates.

2209

6.8
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Patients

Mortality

Stroke

First author

Comments
(n)

(%)

(%)

Deep Hypothermic Circulatory Arrest and Antegrade Cerebral Perfusion and Retrograde
Cerebral Perfusion
Svensson, 2001 (79)

Matalanis, 2003 (80)

DHCA =

DHCA = 0

DHCA

Prospective randomized controlled

10

RCP = 0

=0

study. Neurocognitive results

RCP = 10 ACP = 0

RCP = 0 demonstrate superiority of DHCA

ACP =

ACP =

10

0

in long-term outcome.

DHCA =

DHCA =

DHCA

Retrospective; no significant

14

7.1

=0

differences in mortality or stroke

RCP =

rate among groups

RCP = 23 RCP = 0
ACP =

ACP = 16.0 4.3

25

ACP =
12.0

Sundt, 2008 (81)

DHCA =

DHCA = 7

DHCA

Study showed superiority of ACP

220

RCP = 17

=9

for total arch replacements only;

RCP = 53 ACP = 8

RCP = 9 overall results show no superiority.

ACP =

ACP =

74

5
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Patients

Mortality

Stroke

First author

Comments
(n)

Apaydin, 2009 (82)

Forteza, 2009 (83)

(%)

(%)

DHCA =

Overall

DHCA

Retrospective. No significant

48

mortality=

= 4.1

difference in mortality or stroke

RCP = 94 15.5

RCP = 1 between the perfusion groups.

ACP =

ACP =

19

10

DHCA =

DHCA =

DHCA

Retrospective. All patients with

32

12.5

= 6.2

type A acute dissections. No

RCP = 26 RCP = 23

RCP =

significant difference in mortality

ACP =

11.5

or stroke between groups.

ACP = 8.6

23

ACP =
8.6

Shihata, 2011 (84)

Non-

Non-ACP

Non-

Retrospective, 38% of the non-

ACP =78

=10

ACP

ACP group had RCP as an adjunct

ACP =

ACP = 4

=13

to DHCA. Mortality rates not

ACP =

significantly different.

46

2.2
Misfeld, 2012 (85)

DHCA =

Overall

Non-

No statistical difference in

220

mortality =

ACP

mortality rates between groups.

RCP = 51 11

=15

ACP =

ACP =

365

9
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In this study patients with ACP received brief RCP before terminating DHCA

ACP = antegrade cerebral perfusion; DHCA = deep hypothermic circulatory arrest; PND
= permanent neurologic deficit; RCP = retrograde cerebral perfusion; TND = temporary
neurologic deficit. Reprinted with permission from Ziganshin BA, et al (86).

The data from these studies show very similar stroke and mortality rates when
using DHCA, ACP, or RCP. The small and inconsistent differences in outcomes are not
surprising and likely related to patient selection, disease complexity, and institutional
variations (such as extent of surgical experience with a technique). This shows that all
three techniques are relatively safe and effective cerebral protection methods, and the
choice of which technique to use depends on institutional preference.
While DHCA, ACP, and RCP have similar stroke and mortality rates, there are
still important differences in the pros and especially the cons between the three
techniques. Of the three, RCP is becoming the least popular due to increasing evidence
that very little oxygen actually reaches the brain via venous perfusion because of venous
valves, whose purpose is to prevent exactly what RCP is trying to achieve. Also much of
the retrograde perfusion is diverted via collaterals and never reaches the brain, but rather
is wasted on the soft tissues of the head and upper chest wall (87, 88). The positive
outcomes attributed to RCP (36, 41, 42, 73, 78) may therefore arise from non-oxygen
carrying properties. One major advantage of RCP is that it flushes embolic debris out of
the arterial circulation system and reduces the incidence of air emboli (37). However, our
clinical experience and studies have shown that patients with aortic root aneurysms are
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protected against arteriosclerosis (89, 90), and so debris is not frequently a problem.
Also, DHCA allows for a bloodless and uncluttered field with wide-open exposure of the
aorta, which permits the surgical team to visualize and capture any debris liberated during
aortic debridement and preparation of aortic cuffs for anastomoses (91). DHCA is
therefore intrinsically conducive towards avoiding embolization.
Unlike RCP, which has decreased in popularity, ACP has markedly increased in
popularity in recent years. ACP makes good sense, as it delivers oxygen-rich blood to the
brain, and is the most similar to physiological brain perfusion of the three cerebral
protection techniques. There are, however, several important issues with using ACP, one
of which regards how many vessels should be perfused during ACP, on which there is no
consensus. This is a crucial issue, as adequate and balanced perfusion of all brain
structures is the cornerstone of effective cerebral protection. Some institutions prefer to
perfuse all three of the head vessels (59, 61), including the left subclavian artery, while
others prefer to perfuse just the right axillary and left common carotid artery (50, 60).
Still other institutions believe that unilateral perfusion (innominate artery only) is
sufficient (58, 66, 92).
The other extremely important issue with ACP is that there is no standardization
of appropriate flow rates. Many centers use 8-10 cc/kg/min, which may well be
excessive. High flow rates have been demonstrated to cause cerebral edema (93) and low
flow rates result in cerebral hypoperfusion, defeating the purpose of ACP. ACP can
therefore cause significant cerebral damage, as the balance between hypo- and
hyperperfusion has yet to be optimized. Other issues with the use of ACP include the
potential to cause catheter-induced trauma to head vessels, which are often fragile or
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themselves affected by dissection. Embolization, both air and particulate, is another
danger with using ACP. Particulate embolism is of particular concern, as debris may be
liberated during catheter introduction. All these issues raise concerns about the use of
ACP, especially during emergency cases, such as acute aortic dissections, where there is
little time to spare on establishing a sophisticated perfusion system of the brain.
DHCA, on the other hand, avoids all the previously mentioned concerns with both
RCP and ACP, as well as provides a bloodless and uncluttered field with no intrusive
clamps or perfusion cannulae (31). And, unlike ACP, DHCA is especially appropriate in
emergency situations where time is of the essence and the simplicity of DHCA allows for
immediate life-saving procedures while providing good cerebral protection. DHCA does,
however, raise the issue of how much time under DHCA is safe, on which there is no
consensus as of yet. Some studies have found 20 to 25 minutes to be the safe upper limit
of time under DHCA (65, 94-96), while in our previous studies, we have found that upper
limit to be 40 minutes or more (63).
All in all, DHCA, ACP, and RCP have comparable results in terms of stroke and
mortality rates, with each technique entailing its own set of pros and cons. The choice of
technique is ultimately based on each surgeon’s preference and comfort level. We invited
all members of the Editorial Board of the new journal AORTA (members are listed on
the journal website http://aorta.scienceinternational.org) to fill out an online survey in
which they were asked: which method of cerebral protection do you favor during aortic
arch surgery? The choices they were given were: (1) DHCA; (2) selective ACP; (3) RCP;
(4) DHCA, or cerebral perfusion depending on case complexity. 29 board members
responded with the results shown in Figure 6.
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Figure 6. Pie chart of AORTA Editorial Board members’ preferences in terms of cerebral
protection during aortic arch surgery. Note that almost half of the cardiac surgeons (more
than those with a preference of ACP) responded with a preference of using DHCA (either
alone or with a cerebral perfusion technique depending on the case complexity).
Reprinted with permission from Ziganshin BA (1).

The responses reflect current trends in cerebral protection strategy, with ACP being the
most popular among the surgeons polled (45%) and RCP being the least (7%). It is
interesting, however, to note that almost half of the surgeons (48%), more than those
stating a preference for ACP, preferred using either DHCA or choosing between DHCA
and a cerebral perfusion technique depending on case complexity (1).
Neurocognitive Effects. While the advantages of DHCA are largely undisputed,
there are many conflicting studies on DHCA-related detrimental effects, especially
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neurocognitive. Of the three most commonly used cerebral protection methods, antegrade
cerebral perfusion (ACP), retrograde cerebral perfusion (RCP), and DHCA, Svensson et
al found all 3 to be equivalent in terms of brain injury (by looking at levels of brain injury
markers), but found DHCA to be the superior method in preserving neurocognitive
function (79). We previously published a retrospective clinical study looking at mortality
and post-operative neurological complications that showed using DHCA as the sole
means of cerebral protection is both effective and neurologically safe (63). In another
retrospective study, we showed that in patients with high cognitive needs for their
professions, DHCA had no adverse effect on their reported cognition or work
performance (97). A number of other studies, however, have found DHCA to have a
negative impact on neurologic function (65, 72, 94, 98, 99). Some studies also report a
cutoff time of 20 to 25 minutes under DHCA, above which neurologic deficits may
appear (65, 94-96).
Also, while it is well established in the literature that memory is commonly
negatively affected after cardiac surgery (100, 101), any long-term effects that DHCA
may have on neurocognition, and memory in particular, are relatively unknown. There
have been multiple studies on the temporal nature of neurocognitive deficits incurred
post-operatively in coronary artery bypass graft (CABG) patients. There is some
controversy about the persistence of deficits incurred post-operatively, with some studies
showing the deficits incurred shortly after surgery to persist (102-104), with other studies
showing that deficits resolve in the long term (105, 106). However, when it comes to the
temporal nature of memory deficits incurred after thoracic aortic aneurysm surgery and
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also DHCA, there is a dearth of literature, with only one study to the author’s knowledge
following patients beyond the first follow-up visit at 4 to 6 weeks (72).
Most studies on the neurocognitive effects of DHCA in adults have been
retrospective with either only gross assessment of neurologic function, only qualitative
assessment, or quantitative tests administered only post-operatively. There have been
very few studies that quantitatively measured changes in neurocognitive function based
on scores of tests administered both pre and post-operatively, and even fewer studies that
have followed patients longitudinally past the first post-operative follow-up visit at 4 to 6
weeks. That is precisely the type of study we present here.
We studied patients undergoing only ascending aortic replacement (without
approach to the aortic arch), who did not require DHCA, as a control group. We
compared their function to patients undergoing ascending and arch surgery, our DHCA
group. Thus, both groups were exposed to cardiac surgery and aortic surgery and their
general effects. In fact, this comparison is likely to bias against DHCA, as the DHCA
operations were more extensive and complicated.
A battery of neuropsychometric tests was administered to 62 patients—33
undergoing surgery without DHCA, and 29 undergoing surgery with straight DHCA
(DHCA as the only method used for cerebral protection)—once pre-operatively and then
post-operatively at the first post-operative follow-up visit and again months to a few
years after the after surgery (4.5 months to almost 3 years) with the tests administered
focusing on the areas of memory and processing speed, as those are the two cognitive
domains that have most commonly been shown to be vulnerable for patients undergoing
DHCA (72, 79, 94, 98). We also take a more in depth look at memory, examining
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multiple aspects, instead of accepting a general effect as other studies have done. In
addition, we included in our assessment battery the Clock Drawing Test (CDT), which is
very sensitive for detecting deficits in global cognitive function, executive functions, as
well as the integration of many advanced cortical functions (107).

Aims
We hope to determine if there are any differences in neuropsychometric test
scores between the pre-operative testing and the post-operative testing, both within the
DHCA and non-DHCA groups and between them. We hope also to determine the
temporal nature of any negative effects that DHCA may have on neurocognitive function.

Methods
This study was approved by the Yale University School of Medicine Human
Investigative Committee (number 1210010969).
Patient Population
Patients who were scheduled for surgical repair of an ascending aortic or aortic
arch aneurysm between July 2010 and February 2013 were asked to participate in this
study. Of the 62 total patients enrolled in this study, 29 underwent straight DHCA and 33
did not require DHCA.
In the DHCA group, there were 23 males and 6 females. Mean age was 64.5 years
with a range of 43 to 79 years. 1 patient had Marfan syndrome, and 1 had Loeys-Dietz
syndrome. 2 patients underwent surgical repair for chronic Type A aortic dissections. 11
underwent root-sparing procedures (7 with aortic valve replacement, 4 without aortic
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valve replacement), and 18 underwent root replacement procedures. For the distal
anastomoses, 24 patients had hemiarch replacements and 5 had total arch replacements.
Mean duration under DHCA was 28.2 minutes with a range of 20 to 54 minutes.
In the control group of 33 patients who did not undergo DHCA, there were 27
males and 6 females. Mean age was 58.6 years with a range of 36 to 75 years. There were
no Marfan or Loeys-Dietz syndrome patients. There were no Type A aortic dissection
repairs. 6 patients underwent root-sparing procedures (4 with aortic valve replacement, 2
without aortic valve replacement), and 27 underwent root replacement procedures. There
were no arch resections in this group.
All 62 patients who entered into this study survived surgery with no postoperative strokes or seizures.
In the follow-up study looking at the temporal nature of effects that DHCA had on
neurocognition, the patients consisted of those from the first study who tested positive for
memory deficits based on their neurocognitive testing scores, 11 of whom were in the
DHCA group and 13 of whom were in the non-DHCA group. 5 of these patients, 3 in the
DHCA group and 2 in the non-DHCA group, declined further testing and were therefore
excluded from this follow-up study.
Among the patients completing the follow-up study, in the DHCA group, there
were 6 males and 2 females. Mean age was 65.9 years with a range of 52 to 78 years.
There were no patients with Marfan syndrome or Loeys-Dietz syndrome. 1 patient
underwent surgical repair for chronic Type A aortic dissections. 3 underwent root-sparing
procedures (2 with aortic valve replacement, 1 without aortic valve replacement), and 1
underwent a root replacement procedure. For the distal anastomoses, 4 patients had
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hemiarch replacements and 4 had total arch replacements. Mean duration under DHCA
was 33.8 minutes with a range of 20 to 54 minutes.
Among the patients completing the follow-up study, in the control group of 11
patients who did not undergo DHCA, there were 8 males and 3 females. Mean age was
60.6 years with a range of 44 to 75 years. There were no Marfan or Loeys-Dietz
syndrome patients. There were no Type A aortic dissection repairs. 1 patient underwent a
root-sparing procedure without aortic valve replacement, and 1 underwent a root
replacement procedure. There were no arch resections in this group.
Deep Hypothermic Circulatory Arrest Management
The surgical techniques for induction of deep hypothermia and use of circulatory
arrest were constant for all patients. Total systemic perfusion is usually established by
cannulating the femoral artery, unless the patient is shown to have arteriosclerotic disease
of the descending aorta on intraoperative transesophageal echo or pre-operative computed
tomography. If that is the case, the axillary artery is used for cannulation, or the aneurysm
or distal aorta are cannulated directly. Venous return occurs via the right atrial appendage
with a two-stage cannula (in very rare cases via the femoral vein), and carbon dioxide
instillation into the surgical field is used in all cases. The extent of aortic resection is
determined by the extent of the disease. The patient is put on cardiopulmonary bypass
(CPB) and core cooling occurs. The head is packed in ice for topical cooling. No
barbiturate coma is used during the operation. No electroencephalogram, sensory evoked
potential, or jugular venous bulb oxygen saturation monitoring are used. No special
glucose management techniques are applied. Deep hypothermic circulatory arrest
management is by the Alpha-stat method. The mean core temperature (bladder) during
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DHCA is 18.7°C with a range from 18 to 20°C. Rewarming, which usually takes about
60 minutes, is taken to a temperature of 34 to 36°C. The non-DHCA patients are cooled
to a mean temperature of 24.9°C. The maximum temperature gradient between perfusate
and body temperature during rewarming is kept less than 10°C in order to prevent protein
denaturation (63, 91).
For aortic arch reconstructions, the technique that we have used most commonly
involves a two-vessel island with just the innominate and left common carotid arteries,
instead of the traditional technique of creating a three-vessel Carrel patch (Figure 7).

Figure 7. Aortic arch resconstruction methods. Traditional technique creating a threevessel Carrel patch (left) versus our preferred alternative technique creating a two-vessel
Carrel patch. Reprinted with permission from Gega et al (63).
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The left subclavian artery is re-attached using a small diameter graft either during
rewarming or after termination of CPB. There are several advantages to using this
technique, including an initially smaller Carrel patch suture line, allowing for less time to
be spent under DHCA, and also excellent suture-line access for inspection and additional
placement of hemostatic sutures if needed (63, 91, 108).
Deep hypothermic circulatory arrest was used as the sole means of cerebral
protection. Carbon dioxide flooding of the field was used in all cases. Extent of aortic
resection was determined by the extent of disease, with the goal of excising all severely
dilated aortic segments.
Neurocognitive Tests
A battery of neurocognitive tests was administered by a trained medical student,
pre-operatively at either the office consultation visit or at the time of pre-admission
testing, and post-operatively at the first follow-up visit. The mean time between pre and
post-operative testing among the patients who underwent DHCA was 46.3 days with a
range of 30 to 75 days, and among the patients who did not undergo DHCA the mean was
45.2 days with a range of 31 to 77 days. The battery consisted of three tests that were
chosen, and the results interpreted, with the help of a neuropsychometric specialist: Rey
Auditory Verbal Learning Test (RAVLT), Trail Making Test (TMT)-A and B, and Clock
Drawing Test (CDT). RAVLT tests multiple aspects of memory, including acquisition
(sum of trials A1 through 5), learning rate (difference between trials A5 and A1),
retention (trial A6), delayed recall (trial A7), and recognition (word list). TMT A and B
test attention and processing speed. CDT tests advanced cortical executive functions and
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their integration, as well as global cognitive function (107). “Neurocognitive deficit” was
defined as greater than 20% decline in 2 or more tests (72). (We counted each aspect of
memory that we tested as a separate test.)
In the follow-up study, the RAVLT was administered again to patients months to
years after surgery in order to reassess memory function. In the follow-up study, the
mean time between pre and post-operative testing among the patients who underwent
DHCA was 39.4 days with a range of 30 to 46 days, and among the patients who did not
undergo DHCA the mean was 48.0 days with a range of 27 to 77 days. The mean time
between post-operative and further follow-up testing among patients who underwent
DHCA was 422.4 days with a range of 169 to 1033 days. Among the patients who did not
undergo DHCA, the mean was 653.5 days with a range of 138 to 1089 days.
Patients’ neurological function and status were assessed and tracked both pre and
post-operatively by the intensive care unit and surgical teams.
Statistical Analysis
Very few studies have examined neuropsychometric test score changes after
undergoing DHCA, and so there is no standardized sampling distribution for such score
changes. Therefore, neither a reliable study power nor sample size could be calculated at
the time of study design. However, our sample size of 62 is greater than the mean and
median of the sample sizes of previous such studies, 55.8 and 57, respectively (72, 79,
94, 96, 98). We also retrospectively calculated the sample size necessary to have a power
of 0.8 with a Cohen’s d effect size of 0.8 and the p-values that we found using an on-line
statistical sample size calculator (109). The samples sizes that were calculated were all
smaller than the sample sizes used in each of our statistical tests.
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Analyses of dichotomous variables were done using Fisher’s exact test. Analyses

involving continuous variables were done using the Mann-Whitney U test for data not
normally distributed and student’s t test for normally distributed data. Normal distribution
was assessed using Kolmogorov-Smirnov test. A repeated measures analysis of variance
test was done to assess statistical significances of differences of test scores administered
pre-operatively, post-operatively, and at further follow-up between groups and within
each group. p-values less than 0.05 were considered significant. Statistical analyses were
done using IBM SPSS Statistics software and were reviewed by Yale Center for
Analytical Sciences.
The medical student was the primary person participating in all aspects of this
project from study design to writing the IRB to enrolling patients and data collection to
the statistical analyses of the data to the writing of the manuscripts for this study.

Results
Follow-up at 4-6 weeks post-operatively
The demographic data and surgical characteristics for the non-DHCA and DHCA
groups are presented in Tables 4 and 5, respectively, with no statistically significant
differences between the two groups. Table 6 shows the means and standard deviations of
pre and post-operative neuropsychometric test scores, and the means and standard
deviations of the differences in scores (post minus pre-operative) for the non-DHCA
group and the DHCA group. The means and standard deviations of the differences
between post and pre-operative scores for each group are also depicted in Figure 8.
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Table 4. Patient Demographics

Variable

Non-DHCA

DHCA

Total

33

29

p-value

Sex

1.00

Male

27

23

Female

6

6

Mean Age (range), y

58.6 (36-75)

64.5 (43-79)

0.08

Mean Education (range), y

13.3 (8-18)

13.7 (8-18)

0.65

Marfan syndrome

0

1

0.47

Loeys-Dietz syndrome

0

1

0.47

Stroke, pre-op

0

2

0.50

Post-op neurologic events

0

0

1.00

Pre to post-op test time (range), d

45.2 (27-77)

46.3 (30-75)

0.66

DHCA = deep hypothermic circulatory arrest; post-op = post-operative; pre-op = preoperative.

Table 5. Surgical Characteristics

Variable

Non-DHCA

DHCA

p-value
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Duration DHCA (min), average

0

28.2

n/a

Cooled temperature (°C), average

24.9

18.7

n/a

Root-sparing

6

11

With valve

4

7

0.32

No valve

2

4

0.41

Root replacement

27

18

0.10

Valve-sparing

12

13

1.00

Proximal anastomosis

Distal anastomosis

n/a

Hemiarch

0

24

Total arch

0

5

Type A dissection repair

0

2

0.22

Concurrent CABG

7

3

0.31

Duration CPB (min), average

144.1

150.8

0.38

Duration cross-clamp (min), average 104.3

96.6

0.18

Post-operative hospital stay

5.97

0.91

5.88

(days), average

p-values were listed as n/a for characteristics that were specific to the DHCA group.
CABG = coronary artery bypass graft; CPB = cardiopulmonary bypass; DHCA = deep
hypothermic circulatory arrest.

Table 6. Comparison of Mean Pre and Post-Operative Neuropsychometric Test Scores
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Test

Pre-Op (SD) Post-Op (SD)

Difference (SD)

p-value

Non-DHCA

40.82 (10.32) 38.18 (12.29)

-2.64 (7.21)

0.04

DHCA

37.52 (9.35)

-3.00 (4.46)

0.001

Memory
RAVLT
Acquisitiona

34.52 (10.21)

Non-DHCA vs DHCA

0.19

Learning Rateb
Non-DHCA

4.61 (2.66)

3.94 (9.61)

-0.67 (2.88)

0.19

DHCA

3.69 (1.97)

2.21 (4.40)

-1.48 (3.97)

0.054

Non-DHCA vs DHCA

0.07

Retentionb
Non-DHCA

8.18 (3.02)

7.09 (2.99)

-1.09 (1.72)

0.001

DHCA

7.31 (2.92)

6.28 (2.97)

-1.03 (0.94)

0.00

Non-DHCA vs DHCA

0.26

Delayed Recallb
Non-DHCA

8.27 (3.14)

7.30 (3.06)

-0.97 (1.61)

0.002

DHCA

7.48 (3.11)

6.45 (3.48)

-1.03 (1.18)

0.00

Non-DHCA vs DHCA

0.30

Recognitionb
Non-DHCA

4.61 (2.66)

3.94 (3.78)

-0.67 (2.12)

0.08
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DHCA

3.69 (1.97)

2.21 (4.40)

-0.97 (1.30)

Non-DHCA vs DHCA

0.00
0.63

Processing Speed
Trail Making Test-A (seconds)
Non-DHCA

41.88 (9.61)

40.91 (9.61)

DHCA

47.38 (16.66) 48.35 (17.07)

0.97 (6.67)

0.41

-0.97 (2.69)

0.06

Non-DHCA vs DHCA

0.07

Trail Making Test-B (seconds)
Non-DHCA

91.30 (35.02) 91.91 (34.36)

-0.61 (9.86)

0.73

DHCA

101.79 (36.38) 102.41 (36.85) -0.62 (4.18)

0.43

Non-DHCA vs DHCA

0.25

Executive Function
Clock Drawing Testc
Non-DHCA

9.70 (0.59)

9.70 (0.59)

0.00 (0.00)

n/a

DHCA

9.62 (0.62)

9.62 (0.62)

0.00 (0.00)

n/a

Non-DHCA vs DHCA

a

0.70

Maximum possible score of 65. bMaximum possible score of 15. cScored on a scale of 1

through 10 using the system adapted from Sunderland et al (1989) and Libon et al (1993)
(107). p-values of n/a were for comparisons of equal mean scores. For normative data,
see Appendix. DHCA = deep hypothermic circulatory arrest; post-op = post-operative;

	
  

38	
  

pre-op = pre-operative; RAVLT = Rey Auditory Verbal Learning Test; SD = standard
deviation; vs = versus.

Figure 8. Difference between post and pre-operative scores. Mean and standard deviation
of the difference between post and pre-operative scores for the non-DHCA and DHCA
groups. Note how similar the 2 groups are in all tests. DHCA = deep hypothermic
circulatory arrest.

Memory. In the non-DHCA group, in comparison to baseline pre-operative scores,
there was a decline in post-operative scores seen in the memory areas of acquisition,
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retention, and delayed recall. In the DHCA group, declines were seen in the same
memory areas as seen in the non-DHCA group, but with the addition of recognition.
There were, however, no differences between the non-DHCA and DHCA groups in the
post versus pre-operative scores in any area of memory tested.
Processing speed, executive function, global cognition. There were no declines
seen in processing speed or executive function in either group. In comparing the post and
pre-operative scores between the non-DHCA group and the DHCA group, there were no
differences in any cognitive area tested. It is important to note that there were no changes
in CDT scores post-operatively in all 62 patients, as any changes in CDT scores would
have reflected a change in global cognitive function.
“Neurocognitive deficit”. We also looked at the incidence of “neurocognitive
deficit”, defined as a greater than 20% decline in 2 or more tests, and compared
incidences between the non-DHCA and DHCA groups. In the non-DHCA group, 13
patients incurred a “neurocognitive deficit”, and in the DHCA group 11 patients incurred
a “neurocognitive deficit”. Through Fisher’s exact test, we found no difference in the
incidence of “neurocognitive deficits” in the non-DHCA group versus the DHCA group
(p = 1.00) (Figure 9A).
In addition to assessing for differences in neurocognitive functions between
patients who did or did not undergo DHCA, we also looked to see if there was any
relationship between time under DHCA and incidence of “neurocognitive deficit”. Figure
9B plots all the times under DHCA at which a “neurocognitive deficit” did or did not
occur. Mean time under DHCA was 28.2 minutes with a range from 20 to 54 minutes.
Using the Mann-Whitney U test, we found no difference in time under DHCA between
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those who had a “neurocognitive deficit” versus those who did not (U = 82.50, Z = -0.75,
p = 0.47). It is interesting, however, to note that all 3 patients who underwent DHCA for
longer than 40 minutes experienced a “neurocognitive deficit”.
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Figure 9. Incidence of “neurocognitive deficit”. (A) Number of patients in the nonDHCA group and the DHCA group who experienced a “neurocognitive deficit”. (B)
Scatterplot of the times under DHCA at which a patient did or did not experience a
“neurocognitive deficit”. DHCA = deep hypothermic circulatory arrest.

Follow-up months-years post-operatively
The demographic data and surgical characteristics for the non-DHCA and DHCA
groups are presented in Tables 7 and 8, respectively, with the only statistically significant
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difference between the two groups being duration of cardiopulmonary bypass (CPB),
with the DHCA group undergoing a longer duration of CPB.
Table 7. Follow-Up Patient Demographics

Variable

Totala

Non-DHCA

11

DHCA

p-value

8

Sex

1.00

Male

8

6

Female

3

2

Mean Age (range), y

60.6 (44-75)

65.9 (52-78)

0.25

Mean Education (range), y

13.6 (9-18)

13.6 (8-18)

0.90

Marfan syndrome

0

0

1.00

Loeys-Dietz syndrome

0

0

1.00

Stroke, pre-op

1

0

1.00

Post-op neurologic events

0

0

1.00

Pre to post-op test time (range), d

48.0 (27-77)

39.4 (30-46)

0.09

Post-op to follow-up test time

653.5 (138-1089)

422.4 (169-1033)

0.19

(range), d

a

24 patients had tested positive for memory deficits in the original study, but 5 declined

any follow-up testing. Of the 5, 2 were non-DHCA patients and 3 had undergone DHCA.
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DHCA = deep hypothermic circulatory arrest; post-op = post-operative; pre-op = preoperative.

Table 8. Follow-Up Surgical Characteristics

Variable

Non-DHCA

DHCA

p-value

Duration DHCA (min), average

0

33.8

n/a

Cooled temperature (°C), average

25.3

18.5

n/a

Root-sparing

1

3

0.26

With valve

0

2

0.16

No valve

1

1

1.00

Root replacement

1

1

1.00

Valve-sparing

9

5

0.60

Proximal anastomosis

Distal anastomosis

n/a

Hemiarch

0

4

Total arch

0

4

Type A dissection repair

0

1

0.42

Concurrent CABG

2

2

1.00

Duration CPB (min), average

131.5

171.4

0.01

Duration cross-clamp (min), average

97.0

110.1

0.12

5.25

0.30

Post-operative hospital stay (days), average 5.18
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p-values were listed as n/a for characteristics that were specific to the DHCA group.
CABG = coronary artery bypass graft; CPB = cardiopulmonary bypass; DHCA = deep
hypothermic circulatory arrest.

Of the 19 patients who incurred memory deficits based on the post-operative
testing and who agreed to participate in further follow-up neurocognitive testing months
to years after their surgery (8 who underwent DHCA and 11 who did not), 6 continued to
have memory deficits. 4 of those patients underwent DHCA and 2 did not (p = 0.32).
While there was no statistically significant difference between patients who continued to
have deficits who did or did not undergo DHCA, the patients in the non-DHCA group
continued to have a greater than 20% decline in the same aspects of memory as they did
at the 4 to 6 week post-operative testing, while of the 4 patients in the DHCA group, 3
had a greater than 20% decline in additional memory aspects (Table 9).
Table 9. Deficits in Specific Aspects of Memory

Acquisition

Learning

Retention

Rate

Delayed
Recall

Non-DHCA
Patient 1
4-6 weeks

X

X

X

X

months-years

X

X

X

X

Recognition
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Patient 2
4-6 weeks

X

X

months-years

X

X

4-6 weeks

X

X

months-years

X

DHCA
Patient 3

[X]

X

Patient 4
4-6 weeks

X

months-years

[X]

X

Patient 5
4-6 weeks

X

X

months-years

X

X

4-6 weeks

X

X

months-years

X

X

Patient 6

X
[X]

X

[X]
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[X] signifies additional aspects of memory since the first post-operative testing that
declined by greater than 20% from pre-operative scores. DHCA = deep hypothermic
circulatory arrest.

For all 3 patients, retention was an additional aspect of memory where a decline was seen
at further follow-up. There was no statistically significant difference between the times
under DHCA at which patients did or did not continue to have memory deficits (p = 0.56)
(Figure 10). There was also no statistically significant difference in the days between
surgery and the follow-up test in patients who did or did not have persistent memory
deficits (p = 0.97).
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Figure 10. Time under DHCA and memory deficit resolution. Scatterplot of the times
under DHCA which patients endured and whether their memory deficits resolved or
persisted.

There was a statistically significant difference between patients whose memory
deficits persisted or resolved, and that was age. All 6 patients who had persistent memory
deficits were greater than 70 years old (p < 0.001) (Figure 11).
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Figure 11. Age and memory deficit resolution. Scatterplot of the age of patients and
whether or not their memory deficits resolved or persisted. The dotted line marks 70
years old and note that all patients who memory deficits persisted are over 70 years old.

Table 10 shows the means and standard deviations of memory test scores at the preoperative, post-operative, and follow-up sessions for both DHCA and non-DHCA
patients. When comparing test score across the 3 time points, there were statistically
significant differences between patients under 70 years old and patients over 70 years old
in all aspects of memory tested except in retention.
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Table 10. Comparison of Follow-Up Mean Neuropsychometric Test Scores

Test

Pre-Op (SD) Post-Op (SD)

Follow-Up (SD)

< 70 years old

40.31 (10.40) 34.92 (11.09)

39.85 (11.67)

> 70 years old

33.00 (7.62)

22.50 (8.24)

p-value

Memory
RAVLT
Acquisitiona

23.17 (8.54)

< 70 vs > 70

0.02

Learning Rateb
< 70 years old

3.92 (1.71)

2.31 (4.17)

4.31 (1.49)

> 70 years old

3.00 (2.19)

-2.17 (4.36)

-2.17 (4.58)

< 70 vs > 70

0.01

Retentionb
< 70 years old

7.77 (3.11)

5.69 (3.07)

8.00 (3.16)

> 70 years old

5.50 (2.35)

4.00 (1.67)

3.50 (1.64)

< 70 vs > 70

0.053

Delayed Recallb
< 70 years old

8.15 (3.08)

5.92 (3.09)

8.46 (3.28)

> 70 years old

5.17 (2.64)

3.17 (2.14)

3.33 (2.25)

< 70 vs > 70
Recognitionb

0.02
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< 70 years old

11.77 (2.01)

9.54 (1.94)

11.92 (2.06)

> 70 years old

9.50 (1.38)

7.67 (1.97)

7.17 (1.47)

< 70 vs > 70

a

0.003

Maximum possible score of 65. bMaximum possible score of 15 (107). DHCA = deep

hypothermic circulatory arrest; post-op = post-operative; pre-op = pre-operative; RAVLT
= Rey Auditory Verbal Learning Test; SD = standard deviation; vs = versus.

Discussion
This study adds to the evidence that using straight DHCA for cerebral protection
during ascending aortic surgery is effective in the preservation of neurocognitive function
both in the immediate post-operative period and also long term.
Follow-up at 4-6 weeks post-operatively
Neurocognitive testing battery. We tested two of the most common cognitive
domains thought to be negatively affected after undergoing DHCA, memory and
processing speed, (72, 79, 94, 98) and took the domain of memory, which is often the
most common cognitive domain to be affected after DHCA (96,110), and analyzed
multiple aspects rather than treating it as one general cognitive function as other studies
have done. We also included the Clock Drawing Test in our battery of tests, as this is a
very sensitive indicator of global cognitive dysfunction and also assesses executive
function along with the integration of many cognitive areas (107). In this way, we hoped
to be able to catch any cognitive dysfunction that could be occurring that would not be
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seen by administering only the Rey Auditory Verbal Learning Test and Trail Making
Tests.
Equal neurocognitive preservation as non-DHCA aortic surgeries. By comparing
post-operative scores to the patients’ baseline pre-operative scores, we found no
difference in any cognitive area tested between those who underwent DHCA and those
who did not. We therefore show that patients who undergo aortic arch aneurysm surgeries
using only DHCA for cerebral protection have the same level of neurocognitive
preservation as those who undergo less extensive ascending aortic aneurysm surgeries
without DHCA.
Time under DHCA. On top of analyzing the effects of DCHA on neurocognitive
function, we also looked at the relationship between time under DHCA and changes in
neurocognition, as time under DHCA has been shown in other studies to be an important
determinant of decline in neurocognitive function, with a cutoff time point cited between
20 to 25 minutes (65, 94-96) or beyond 40 minutes (63). Defining a “neurocognitive
deficit” as experiencing a greater than 20% decline from baseline in 2 or more tests based
on a previous neuropsychometric study done by Harrington et al (72), we found there to
be no relationship between incidence of “neurocognitive deficit” and time under DHCA
(range of 20 to 54 minutes). However, we did notice that all 3 patients who were under
DHCA for longer than 40 minutes experienced a “neurocognitive deficit”, so a larger
study might reveal a statistical correlation with DHCA time. That would support our
previous study, in which we found that time under DHCA for 40 minutes or longer leads
to an increased risk of neurologic impairment (63). It is important to note that although
we have applied the term “neurocognitive deficit”, based on the detailed
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neuropsychometrics and clinical observations, these patients were in excellent clinical
neurologic status, with no detectable clinical issues or abnormalities, or discernible
impairments in daily life, school, or work.
Memory. While we found no difference in the post versus pre-operative test
scores between the non-DHCA group and the DHCA group, there was a decline in
function seen in certain areas of memory post-operatively within both groups, namely
acquisition, retention, and delayed recall. In the DHCA group, a decline in recognition
was also seen. Processing speed and executive function were not affected. This finding
that memory is negatively affected after cardiac surgery is not surprising, as this has been
well established in the literature (100, 101). One possible mechanism behind this is in the
metabolic nature of the hippocampus. The hippocampus plays a critical role in memory
formation, but it has a high metabolic rate and so is particularly sensitive to ischemic
injury (111-113). What is interesting, however, is that we found only specific aspects of
memory to be affected after cardiac surgery, and also, that learning rate does not seem to
be affected by cardiac surgery at all, in either the non-DHCA or the DHCA group. We
were interested to know if the subtle alterations in measures of memory are durable or
improve over time, as our testing was done relatively early after the surgical procedures
(mean 36.4 days), and so we followed up with patients at a time-point of months to years
after their surgeries.
Follow-up months-years post-operatively
DHCA Does Not Affect Recovery from Memory Deficits. In our previous study,
we found that there was no difference between patients who underwent DHCA and those
who did not in the occurrence of neurocognitive deficits incurred post-operatively. The
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question then became: Are the deficits that were incurred short-term or long-term, and
does undergoing DHCA affect the temporal nature of these deficits. In this study,
following up with those patients who did test early-positive for memory deficits, with
follow-up months to years post-operatively, we found no difference in terms of recovery
from or persistence of memory deficits in patients who did or did not undergo DHCA.
Time under DHCA was also found to have no effect on the resolution or persistence of
memory deficits, confirming findings by Harrington et al, which was the one study that
followed patients beyond 4 to 6 weeks (72). The time between surgery and further
follow-up testing did vary among patients, but it was also found that there was no
difference in the time between further follow-up testing and surgery in patients who did
or did not recover from their memory deficits.
Effects of Age. While DHCA was not found to affect the resolution or persistence
of memory deficits incurred post-operatively, we found age to significantly affect the
temporality of memory deficits. Specifically, whether a patient was over or under 70
years old was found to be a significant difference between patients who did or did not
recover from their memory deficits, with all 6 patients who were over 70 years old having
persistent memory deficits.
This finding is well-supported by the literature on both open heart surgeries and
general surgeries, where it is well established that age is risk factor for post-operative
cognitive decline, and that the elderly have a higher incidence of long-term postoperative cognitive decline, with memory being the most commonly affected cognitive
area (101, 114-117). The cause of this has to do with the fact that the brain of an elderly
person is different from the brain of a younger person. Important differences include size,
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distribution and type of neurotransmitters, metabolic function, and the capacity for
plasticity (101).
Memory Deficits in DHCA Patients that Persist Tend to Worsen. Although DHCA
was found to have no significant effect on whether or not patients recovered from
memory deficits incurred post-operatively, we did find that in patients who did have
persistent memory deficits, those who underwent DHCA seemed to have declines in
additional aspects of memory than what they manifested previously, particularly
retention, while those who did not undergo DHCA had declines in the same aspects of
memory as they did originally. It has previously been shown in 2 studies that in patients
who undergo DHCA, poor neuropsychometric outcomes at early follow-up is a predictor
of persistent poor outcomes at a later follow-up, with later follow-up occurring at 6
weeks in one study and 12 to 24 weeks in the other (72, 96). Our study includes
neuropsychometric follow-up 24 weeks to over 2 years post-operatively, and so we build
upon previous studies by showing that if memory deficits persists past 24 weeks in
patients who underwent DHCA, then in those patients, the deficits tend to worsen to
affect additional aspects of memory. This leads to the question of why this occurs and
further studies are needed to investigate the mechanism behind this finding. It should be
emphasized that these deficits are subclinical—only elicited by detailed investigative
testing, and manifested in only a very small subgroup of all patients undergoing DHCA.
Limitations
While there are no statistically significant differences in demographic data and
surgical characteristics between the non-DHCA group and DHCA group, the nature of
the indication for DHCA is such that those in the DHCA group were undergoing a more
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extensive surgery (aortic arch involved), whereas in the non-DHCA group, the arch was
not involved, and so there was no indication for DHCA. However, the fact that the nonDHCA group patients underwent simpler and less extensive procedures should suggest
that the non-DHCA group would experience a smaller decrease in scores post-operatively
than the DHCA group. Since we found no difference in post versus pre-operative scores
between the non-DHCA and DHCA groups, the less extensive surgical procedures
undergone by the non-DHCA group lends strength to our findings. Also, while there was
no statistically significant difference in the ages of the two groups, the average age of the
non-DHCA patients (58.6 years) was younger than that of the DHCA patients (64.5
years). In essence, despite biases against the DHCA group, brain preservation was still
equivalent despite DHCA.
Another limitation of our study was that we primarily focused on assessing the
cognitive domains of memory and processing speed. There are other cognitive areas that
could be assessed. However, we incorporated the CDT in order to compensate for other
cognitive areas. CDT assesses executive function along with many other advanced
cortical functions, as well as the integration of various functions. CDT is also very
sensitive in detecting global cognitive dysfunction (107). We therefore believed the CDT
to be an adequate test to detect cognitive areas besides memory and processing speed that
may experience a deficit after DHCA.
In this study, we showed that time under DHCA does not affect neurocognition.
However, as mentioned previously, this study only had 3 patients who underwent DHCA
for 40 minutes or longer, with most of the patients being under DHCA for less than 30
minutes. We therefore recognize that our sample size for patients under prolonged DHCA
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time was not very large. However, this study shows that longer DHCA times are rarely
required even in a vigorous aortic practice. Our previous clinical study found a ceiling
time of 40 minutes DHCA to be safe (63), while other studies have shown a time range of
20 to 25 minutes as the upper limit of safe duration under DHCA (65, 94-96). Our mean
and median DHCA times were 28.2 and 27 minutes, respectively, and only above 40
minutes was any suspicion raised by the present study. We feel we can confidently say
that time under DHCA up to 25 minutes, and likely up to 40 minutes, does not negatively
affect neurocognitive function. It is also important to remember that clinical, and likely
sub-clinical, neurological dysfunction are multi-factorial, with air and particulate
embolization playing a major role, especially in open aortic surgery (63). Those factors,
of course, are technical and not directly related to DHCA duration.
In terms of the long term follow-up portion of this investigation, that part of the
study is limited by its small sample size, and we recognize that the cohort of patients
participating in this study may not be representative of other patient populations, and that
a study with a larger sample size may produce different results. However, our study is the
only study to the author’s knowledge that investigates the effects of DHCA on the longterm nature of memory deficits incurred post-operatively. Our study therefore provides
important novel findings that will hopefully stimulate further studies in this area.
Conclusions
In conclusion, we augment evidence that using DHCA as the sole means of
cerebral protection during ascending aortic surgery is effective at preserving
neurocognitive function both in the short and long-term. Time under DHCA for less than
40 minutes is found to not be an important contributor to quantitatively measured
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neurocognitive outcome. In addition, we show that while DHCA does not affect whether
or not memory deficits incurred post-operatively persist, what does affect the temporal
nature of memory deficits is age, with patients over the age of 70 having a higher
incidence of persistent long-term memory deficits. This study therefore shows that when
considering the long-term neurocognitive outlook for aortic arch aneurysm patients, it is
not the DHCA technique that comes into question, but the age of the patient. We do
show, however, that whether by comparing raw scores or by comparing incidence of
“neurocognitive deficits”, DHCA is an effective technique for the preservation of
neurocognitive function.
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